Hoping for a discounted penalty, fintech iSignthis has won its bid to adduce evidence of without prejudice offers it made to reach a resolution with ASIC before the regulator took it to court.
Bayer has filed a High Court challenge to a decision that invalidated its patents for blockbuster blood thinner Xarelto, saying it would adversely affect drug research and development.
The federal government spent more than $600 million on private law firms in 2022-23, and Clayton Utz was the firm the government turned to the most.
A class action against water treatment company Phoslock and auditor KPMG should not be held up until a shareholder that’s stuck in preliminary discovery proceedings files a competing case, a court has heard.
Health Workers Union secretary Diana Asmar wants to halt a case by the Fair Work Commission over an alleged $2.7 million false invoicing scheme, saying criminal proceedings were “on the cards”.
Bird & Bird has hired DLA Piper technology and data protection partner Nicholas Boyle to join the firm’s Sydney office.
US animal drug manufacturer Zoetis has lost its challenge a ruling that chucked out three of its patents for a single-dose vaccine to protect pigs from enzootic pneumonia.
A judge has balked at a suggestion by group members appealing a $112 million Robodebt class action settlement that the Commonwealth could represent the interests of people content with the deal.
Swiss pharmaceutical giant Novartis has lost its patent infringement case against Sydney-based generics company Pharmacor over a top-selling heart medication.
ASIC wants the Full Court to overturn a finding that Noumi waived privilege over a PwC report produced under a voluntary disclosure regime, arguing the regime benefits the public in making investigations more efficient.